TY - JOUR
KW - Dapsone
KW - Drug Therapy, Combination
KW - Ethionamide
KW - Humans
KW - leprosy
KW - Rifampin
AU - Pattyn S R
AU - Husser J A
AU - Saint-André P
AB - <p>Ten patients infected with mouse proven DDS-resistant bacilli were treated with the following combined regimen: RMP 600 2/7 6 months, ETH 500 7/7 6 months and DDS 100 7/7 12 months. Follow up was for 27-54 months, without relapses. Added to patients from previous study (Int. J. Lepr. 1984, 52, 297-303) the 95% confidence limit decreases from 12 to 9%.</p>
BT - Acta leprologica
C1 - http://www.ncbi.nlm.nih.gov/pubmed/3296614?dopt=Abstract
DA - 1986 Oct-Dec
IS - 4
J2 - Acta Leprol
LA - fre
N2 - <p>Ten patients infected with mouse proven DDS-resistant bacilli were treated with the following combined regimen: RMP 600 2/7 6 months, ETH 500 7/7 6 months and DDS 100 7/7 12 months. Follow up was for 27-54 months, without relapses. Added to patients from previous study (Int. J. Lepr. 1984, 52, 297-303) the 95% confidence limit decreases from 12 to 9%.</p>
PY - 1986
SP - 445
EP - 6
T2 - Acta leprologica
TI - [Efficacy of combined treatments comprising 6 months' administration of rifampicin in multibacillary leprosy].
VL - 4
SN - 0001-5938
ER -